Victoza and Hepatic function abnormal - a phase IV clinical study of FDA data

Summary:

Hepatic function abnormal is reported as a side effect among people who take Victoza (liraglutide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Amaryl, and have High blood pressure.

The phase IV clinical study analyzes which people have Hepatic function abnormal when taking Victoza. It is created by eHealthMe based on reports of 42,028 people who have side effects when taking Victoza from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,440 drugs and 2,021 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.

On Jul, 19, 2026

42,028 people reported to have side effects when taking Victoza.
Among them, 38 people (0.09%) have Hepatic function abnormal.

Could Victoza cause Hepatic function abnormal?

Among these 38 people:

How long have people been on Victoza when they have Hepatic function abnormal? *

What is the gender of people who have Hepatic function abnormal when taking Victoza? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Hepatic function abnormal when taking Victoza? *

What are other drugs people take besides Victoza? *

What are other side effects people have besides Hepatic function abnormal? *

Diarrhea: 5 people, 13.16%
Liver Function Test Abnormal: 3 people, 7.89%
Death: 2 people, 5.26%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 5.26%
Diabetes Mellitus Inadequate Control: 2 people, 5.26%
Nausea (feeling of having an urge to vomit): 2 people, 5.26%
Constipation: 2 people, 5.26%
Fever: 2 people, 5.26%
Bacteraemia (presence of bacteria in the blood): 2 people, 5.26%
Anaemia (lack of blood): 2 people, 5.26%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 10.53%
Pain: 2 people, 5.26%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 5.26%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 2.63%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 2.63%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 2.63%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 1 person, 2.63%
Multiple Myeloma (cancer of the plasma cells): 1 person, 2.63%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 2.63%
Kidney Transplant Rejection: 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Victoza:

Victoza (42,880 reports)

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic function abnormal:

Hepatic function abnormal (1,440 drugs)

Browse all the conditions that are associated with Hepatic function abnormal:

Hepatic function abnormal (2,021 conditions)

Related publications that referenced our studies

Fontoura P, de Almeida Cardoso MC, Erthal-Martins MC, Werneck C, Sartorio C, Ramos CF, "The effects of liraglutide on male fertility: a case report", Reproductive biomedicine online, 2014 Nov .
Fontoura P, de Almeida Cardoso MC, Erthal-Martins MC, Werneck C, Sartorio C, Ramos CF, "The effects of liraglutide on male fertility: a case report", Reproductive biomedicine online, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on liraglutide (the active ingredients of Victoza) and Victoza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.